ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
The ELZA Institute heads to Jeddah for the first SSCRS congress, 24–26 September 2026. Prof. Farhad Hafezi and Nikki Hafezi present four talks spanning personalised cross-linking, epi-on CXL, corneal biomechanics and ELZA-PACE.
Corneal imaging in keratoconus – Scheimpflug tomography, OCT and epithelial mapping – now catches the disease years earlier. How modern scans work, from ELZA.
A new ELZA review in Die Ophthalmologie examines the mechanisms, clinical evidence, protocol selection, and indications for PACK-CXL in infectious keratitis.
Nikki and Farhad Hafezi represented ELZA at Vision China 2026, presenting work on keratoconus epidemiology, corneal cross-linking, K-MAP and international research collaboration.
Dr Abha Gour from Dr Shroff’s Charity Eye Hospital visited ELZA to discuss visual rehabilitation in keratoconus, including ELZA-PACE and corneal wavefront-guided TransPRK.
As the Eye Clinic KBC Zvezdara celebrates 60 years, current debates in ophthalmology focus on the shift from standardized protocols to personalized treatment for keratoconus and corneal ectasia.
